The seed yield potential of Phaseolus genotypes varies according their genetic background, environmental conditions, agronomic management, presence of pathogens, and/or their interactions. We evaluated the agronomic performance of 27 common bean (Phaseolus vulgaris L.) and three tepary bean (P. acutifolius A. Gray) genotypes and their response to ashy stem blight (ASB) caused by Macrophomina phaseolina (Tassi) Goidanich. The 30 bean genotypes were planted in Isabela and Lajas, Puerto
Pigeonpea [Cajanus cajan (L.) Mill.] cultivar 'Lázaro' (Reg no. CV-331, PI 692612) was developed in the United States at the Isabela and Lajas Research Substations at the University of Puerto Rico in collaboration with researchers at the University of California, Riverside. Lázaro was derived from the bi-parental cross '2B-Bushy'/OP-61 and traces back to the selection of F 2 individual plants insensitive to long daylength (>12 h) and advanced by a combination of pedigree and bulk breeding methods. Lázaro is photoperiod insensitive, and its yield performance was tested in six environments with checks in Puerto Rico and under furrow and drip irrigation systems in California in 2017 and 2018. Lázaro has a determinate growth habit, initiates flowering from 69 to 94 d, reaches harvesting maturity between 130 to 149 d, and has a small beige seed (17 g per 100 seeds). Mean seed yield varied from 338 to 1,091 kg ha −1 in Puerto Rico and >3,300 kg ha −1 in California. Furthermore, Lázaro can be planted year-round compared with cultivars 'Cortada', 'Guerrero', and 'ICP 7035', which are photoperiod sensitive and thus only recommended for planting under short-daylength conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.